Queenland, Australia

Andrew W Boyd




Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Melbourne, AU (1998)
  • Ascot Vale, AU (1994 - 2003)
  • Queensland, AU (2008)
  • Queenland, AU (2011)
  • Fitzroy North, AU (2020)

Company Filing History:


Years Active: 1994-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Andrew W Boyd: Innovating Neurological Treatments in Queensland, Australia

Introduction

Andrew W Boyd is a notable inventor hailing from Queensland, Australia, recognized for his significant contributions to the field of medical research. With a total of eight patents to his name, Boyd has made strides in developing methodologies aimed at treating various diseases, particularly those affecting the nervous system.

Latest Patents

Among his latest patents is the innovation surrounding mammalian EphA4 polypeptide derivatives that are engineered to lack one or more N-glycosylation sites. This invention is particularly important for treating diseases exacerbated by the signaling pathways of the erythropoietin-producing hepatoma receptor kinases, specifically EphA4. His work focuses on identifying agents that can potentially counter these diseases effectively. Another significant patent involves a method of treatment that manipulates the expression of Eph receptors or their functional equivalents to either increase or decrease functionality based on the specific condition being addressed. This innovative approach promises to provide new avenues for tackling disorders of the nervous system stemming from injury or other diseases.

Career Highlights

Throughout his career, Boyd has collaborated with prestigious institutions, including Amrad Corporation Limited and the Walter and Eliza Hall Institute of Medical Research. His dedication to advancing medical treatments through innovation has positioned him as a key inventor in his field.

Collaborations

Andrew W Boyd has worked alongside numerous talented individuals, including Richard John Simpson and Larry David Ward. These collaborations have been instrumental in his success, fostering an environment of shared knowledge and expertise that enhances the innovation process.

Conclusion

In summary, Andrew W Boyd stands out as an influential figure in the realm of medical research and invention. His extensive work on EphA4 polypeptide derivatives and treatment methodologies highlights the importance of innovation in addressing pressing health challenges. Through his patents and collaborations, Boyd continues to contribute meaningfully to the advancement of therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…